Abhishek, A., Boyton, R., Peckham, N., McKnight, Á., Coates, L., Bluett, J., . . . investigators, V. s. (2022). Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): A randomised, open label, superiority trial. Elsevier.
Chicago Style (17th ed.) CitationAbhishek, A., et al. Effect of a 2-week Interruption in Methotrexate Treatment Versus Continued Treatment on COVID-19 Booster Vaccine Immunity in Adults with Inflammatory Conditions (VROOM Study): A Randomised, Open Label, Superiority Trial. Elsevier, 2022.
MLA引文Abhishek, A., et al. Effect of a 2-week Interruption in Methotrexate Treatment Versus Continued Treatment on COVID-19 Booster Vaccine Immunity in Adults with Inflammatory Conditions (VROOM Study): A Randomised, Open Label, Superiority Trial. Elsevier, 2022.